Fingerprint
Dive into the research topics of 'Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetes
Philip Raskin, E. B. Rappaport, S. T. Cole, Y. Yan, R. Patwardhan, M. I. Freed
Research output: Contribution to journal › Article › peer-review
209
Scopus
citations